Cargando…

Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients

Peritoneal hyalinizing vasculopathy (PHV) represents the cornerstone of long-term peritoneal dialysis (PD), and especially characterizes patients associated with encapsulating peritoneal sclerosis. However, the mechanisms of PHV development remain unknown. A cross sectional study was performed in 10...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz, Raquel, Sandoval, Pilar, Rodrigues-Diez, Raul R., del Peso, Gloria, Jiménez-Heffernan, José A, Ramos-Ruíz, Ricardo, Llorens, Carlos, Laham, Gustavo, Alvarez-Quiroga, Mabel, López-Cabrera, Manuel, Ruiz-Ortega, Marta, Bajo, María A., Selgas, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461593/ https://www.ncbi.nlm.nih.gov/pubmed/32823722 http://dx.doi.org/10.3390/ijms21165824

Ejemplares similares

Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013)

Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis
por: Ossorio, Marta, et al.
Publicado: (2017)

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications
por: González, Elena, et al.
Publicado: (2016)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

Actinomyces peritonitis: removal of the peritoneal catheter unnecessary for resolution
por: Díaz, R., et al.
Publicado: (2010)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
por: Marchant, Vanessa, et al.
Publicado: (2020)

T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage
por: Liappas, Georgios, et al.
Publicado: (2015)

Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients
por: Ruiz-Carpio, Vicente, et al.
Publicado: (2017)

An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study
por: Gonzalez, Elena, et al.
Publicado: (2015)

Corrigendum to “T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage”
por: Liappas, Georgios, et al.
Publicado: (2017)

Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
por: Loureiro, Jesús, et al.
Publicado: (2013)

Kocuria salsicia peritonitis in a peritoneal dialysis patient
por: Fernández Girón, Fernando, et al.
Publicado: (2023)

Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition
por: Pérez-Lozano, María Luisa, et al.
Publicado: (2013)

Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT
por: González-Mateo, Guadalupe Tirma, et al.
Publicado: (2015)

Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial
por: Fontana, Francesco, et al.
Publicado: (2020)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists
por: Ossorio, Marta, et al.
Publicado: (2018)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis Complicated by Sclerosing Peritonitis
por: Jiang, Zhifeng, et al.
Publicado: (2022)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

The time for surgery of peritonitis associated with peritoneal dialysis
por: Mihalache, O, et al.
Publicado: (2016)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

Evaluation of a system for sorbent‐assisted peritoneal dialysis in a uremic pig model
por: van Gelder, Maaike K., et al.
Publicado: (2020)

Peritoneal dialysis fluid biocompatibility impact on human peritoneal membrane permeability
por: Rodríguez-Esparragón, Francisco, et al.
Publicado: (2018)

Peritoneal-pleural leak improved by switching from continuous ambulatory peritoneal dialysis to automated peritoneal dialysis
por: Jung, Jong Hwan
Publicado: (2018)

Continuous Ambulatory Peritoneal Dialysis Peritonitis Guidelines – Consensus Statement of Peritoneal Dialysis Society of India - 2020
por: Jeloka, Tarun K., et al.
Publicado: (2021)

Calcium balance in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) cyclers
por: Davenport, Andrew
Publicado: (2023)

Evidence on continuous flow peritoneal dialysis: A review
por: de Vries, Joost C., et al.
Publicado: (2022)

Peritoneal dialysis in Peru
por: Vélez-Segovia, E., et al.
Publicado: (2014)

Psychiatrist and Peritoneal Dialysis
por: Klarić, D., et al.
Publicado: (2022)

Peritoneal dialysis: why not?
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2023)

Prescribing and peritoneal dialysis
por: Reimann, Frank, et al.
Publicado: (2023)

COVID-19 vaccination in peritoneal dialysis patients
por: Htay, Htay, et al.
Publicado: (2022)

A Case of Peritoneal Dialysis-related Peritonitis Caused by Aeromonas Hydrophila in the Patient Receiving Automated Peritoneal Dialysis
por: Kim, Hyun Jin, et al.
Publicado: (2018)

Overhydration and low serum prealbumin predict peritoneal dialysis-related peritonitis in continuous ambulatory peritoneal dialysis patients
por: Dao Bui Quy, Quyen, et al.
Publicado: (2020)

Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization
por: Dai, Rong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_45cv0tkcohuuk18pj0j742p9q1